Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
2.
Article in Chinese | MEDLINE | ID: mdl-35822383

ABSTRACT

Objective:To investigate the effect of transoral endoscopic thyroid surgery in the central lymph node dissection of thyroid cancer. Methods:Twenty patients underwent endoscopic thyroidectomy via oral vestibular approach (TOETVA group) and 20 gender and age matched patients underwent conventional open thyroidectomy were selected in this study. The clinical data, number of lymph node dissection and postoperative complications of the two groups were collected and analyzed. SPSS 24.0 statistical software was used for data analysis. Results:There was no significant differences in age, BMI, tumor size or the number of Hashimoto's thyroiditis patients between the TOETVA group and the open group(P>0.05). The operation time([117.30±10.54]min) and postoperative drainage volume([146.05±30.66]mL) in the TOETVA group were significantly higher than those in the open group([59.05±6.40]min, [77.90±22.18]mL), P<0.001. The pain in the open group 24 h after surgery was more severe than that in the TOETVA group(P<0.05). The total number of central lymph nodes, the number of pre-laryngeal lymph nodes and the number of pre-tracheal lymph nodes cleared by the two groups were similar, and the number of final positive lymph nodes had no significant difference. However, the number of paratracheal lymph nodes removed in the TOETVA group was more(7.8±4.2) nodes than that in the open group(6.4±3.9) nodes, P<0.05. There was no significant difference in postoperative complications between the two groups. The scores of cosmetic evaluation and rating of cicatrices in the TOETVA group six months after surgery were(0.77±0.58) significantly lower than those in the open group(4.30±1.54), P<0.001. Conclusion:In central lymph node dissection, the efficiency of TOETVA is similar to that of traditional open thyroid surgery. For special anatomical regions, endoscopic surgery is more efficient. At the same time, TOETVA does not increase the incidence of related complications, and has good cosmetic effect.


Subject(s)
Thyroid Neoplasms , Humans , Neck Dissection , Postoperative Complications/surgery , Thyroid Neoplasms/pathology , Thyroid Neoplasms/surgery , Thyroidectomy
3.
J Int Med Res ; 49(3): 300060521996515, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33752469

ABSTRACT

OBJECTIVES: To identify key long non-coding (lnc)RNAs responsible for the epithelial-mesenchymal transition (EMT) of CNE1 nasopharyngeal carcinoma cells and to investigate possible regulatory mechanisms in EMT. METHODS: CNE1 cells were divided into transforming growth factor (TGF)-ß1-induced EMT and control groups. The mRNA and protein expression of EMT markers was determined by real-time quantitative PCR and western blotting. Differentially expressed genes (DEGs) between the two groups were identified by RNA sequencing analysis, and DEG functions were analyzed by gene ontology and Kyoto Encyclopedia of Genes and Genomes analyses. EMT marker expression was re-evaluated by western blotting after knockdown of a selected lncRNA. RESULTS: TGF-ß1-induced EMT was characterized by decreased E-cadherin and increased vimentin, N-cadherin, and Twist expression at both mRNA and protein levels. Sixty lncRNA genes were clustered in a heatmap, and mRNA expression of 14 dysregulated lncRNAs was consistent with RNA sequencing. Knockdown of lnc-PNRC2-1 increased expression of its antisense gene MYOM3 and reduced expression of EMT markers, resembling treatment with the TGF-ß1 receptor inhibitor LY2109761. CONCLUSION: Various lncRNAs participated indirectly in the TGF-ß1-induced EMT of CNE1 cells. Lnc-PNRC2-1 may be a key regulator of this and is a potential target to alleviate CNE1 cell EMT.


Subject(s)
Nasopharyngeal Neoplasms , RNA, Long Noncoding , Cadherins , Epithelial-Mesenchymal Transition , Humans , Nasopharyngeal Carcinoma/genetics , Nasopharyngeal Neoplasms/genetics , RNA, Long Noncoding/genetics , Receptors, Cytoplasmic and Nuclear , Trans-Activators , Transforming Growth Factor beta1/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...